Genmab A/S (GMAB) Reports 2022 Net Sales of DARZALEX of $7.98B
Go back to Genmab A/S (GMAB) Reports 2022 Net Sales of DARZALEX of $7.98B| (NASDAQ: GMAB) | Delayed: 33.48 +0.07 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.41 | 52 Week High | $ | |||
| Open | $33.36 | 52 Week Low | $ | |||
| Day High | $33.98 | P/E | N/A | |||
| Day Low | $33.30 | EPS | $ | |||
| Volume | 1,278,290 | |||||
